EffPha meets you at BIO Asia- Taiwan Exhibition 2025
Exhibitor: EFFICIENT PHARMA MANAGEMENT CORP.
Date: 2025-06-26
Booth No.: M919
EffPha is a full-service CRO providing drug development services, including strategic and technical consulting, non-clinical study management, biostatistics, data management, regulatory dossier preparation and submission, and clinical study management and monitoring.
EffPha has a team of Scientific Directors with more than 30 years of experience in global drug development, the Senior Manager who has designed numerous clinical protocols with extensive experience in regulatory affairs, the Clinical Director with over 25 years of experience in clinical management and monitoring, and the Manager of Biostatistics and Data Management who excels at statistical analysis plan (SAP) design and handling of clinical data analysis. They will be present at our booth to interact with visitors. We warmly welcome you to visit us at BIO Asia- Taiwan Exhibition 2025, and we are open to discussing any questions you have related to drug development and/or clinical trials.
Also, you can learn more details of EffPha’s services on our website at https://www.effpha.com/ as well as via our company video by clinking the link < https://www.youtube.com/watch?v=SZxxmSuppeA >
Come visit EffPha at our booth number M919 in the CRO zone on the 4th floor, at the Nangang Exhibition Center Hall 1 (4F, No.1, Jingmao 2nd Rd., Nangang District, Taipei City, Taiwan). Upon entering through the entrance of the M zone, please walk straight ahead.
Date|Thursday, July 24th – Sunday, July 27th, 2025
Time|10:00 AM ~ 6:00 PM (The exhibition will end at 5:00 PM on the last day.)
More Exhibitor's Press Release
- EffPha – An expert-based CRO for your drug development EFFICIENT PHARMA MANAGEMENT CORP. / 2025-06-26
- GoldenBiotech Seminar:Advancing First-Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 GOLDEN BIOTECHNOLOGY CORP. / 2025-06-26
- FullGreen Unveils LNP Platform to Boost API Absorption & Revolutionize Pharma/Nutraceuticals FULLGREEN SUSTAINABLE BIOMEDICAL TECHNOLOGY CO.,LTD / 2025-06-26
- FullGreen Debuts Next-Gen API Synthesis & Smart QC Platform, Ushering in Efficient Pharma Production FULLGREEN SUSTAINABLE BIOMEDICAL TECHNOLOGY CO.,LTD / 2025-06-26
- The Ultimate Boost for Aesthetic Brands—Redefining the Limits of Ceramide Applications! FULLGREEN SUSTAINABLE BIOMEDICAL TECHNOLOGY CO.,LTD / 2025-06-26
- Panlabs Biologics Expands Functional Bioactive Ingredient Portfolio to Empower Biotech-Based Beauty PANLABS BIOLOGICS INC. / 2025-06-25
- Panlabs Biologics Partners with ATRI to Introduce Pichia pastoris Expression System, Strengthening L PANLABS BIOLOGICS INC. / 2025-06-25
- New Launch! IPI Pathoslide® 2.0 – Redefining Slide Coverslipping for Modern Labs J & H TECHNOLOGY CO., LTD. / 2025-06-25
- Unireal Technology to Exhibit High-Performance Japanese Processing Equipment at BIO Asia–Taiwan 2025 UNIREAL TECHNOLOGY CO., LTD / 2025-06-24
- Reagent Dispenser — Biodisp-1 MEDCLUB SCIENTIFIC CO., LTD. / 2025-06-24
- TaiMed at BIO Asia 2025: Advancing Long-Acting HIV Therapy and Innovative ADC Platform TAIMED BIOLOGICS INC. / 2025-06-24
- Professional Sample Preparation Before Sequencing Overall Solution MEDCLUB SCIENTIFIC CO., LTD. / 2025-06-24
- See Clearly, Count Accurately-Leap-Count Cell Counter Launched MEDCLUB SCIENTIFIC CO., LTD. / 2025-06-24
- Microbial CRO R&D Service Platform (Strain Optimization / Process Development) PANLABS BIOLOGICS INC. / 2025-06-23
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 XIN TOP CORPORATION / 2025-06-23
- Uncountable Welcomes BlueNalu as a New Customer, Advancing The Future of Cell-Cultured Seafood UNCOUNTABLE INC. / 2025-06-20
- Mission and Value Proposition of Ducolege Biotechnology DUCOLEGE BIOTECHNOLOGY CO., LTD. / 2025-06-18
- NTHU team achieves breakthrough in breast cancer chemoresistant targeted therapy LILY WANG LAB NTHU / 2025-06-18
- Developing novel therapeutics for Alzheimer’s disease and neurodegenerative disorders NEURAL REJUVENATION TEAM, ACADEMIA SINICA / 2025-06-18
- Innovative Microfluidic Liquid Biopsy System Offers a New Solution for Colorectal Cancer Recurrence CELLENVISION COMPANY LIMITED / 2025-06-18